Bill Text: HI HB2631 | 2018 | Regular Session | Amended
Bill Title: Relating To The Electronic Prescription Accountability System.
Spectrum: Slight Partisan Bill (Democrat 9-3)
Status: (Engrossed - Dead) 2018-03-28 - The committee on CPH deferred the measure. [HB2631 Detail]
Download: Hawaii-2018-HB2631-Amended.html
HOUSE OF REPRESENTATIVES |
H.B. NO. |
2631 |
TWENTY-NINTH LEGISLATURE, 2018 |
H.D. 1 |
|
STATE OF HAWAII |
S.D. 1 |
|
|
|
|
|
||
|
A BILL FOR AN ACT
RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that opioid addiction is a growing problem in Hawaii. According to data from the federal Centers for Disease Control and Prevention, drug overdose deaths in Hawaii increased by eighty-three percent from 2006 to 2014, a growth rate more than double the national average of thirty-seven percent. Nearly half of those deaths are a result of prescription opioids.
Furthermore, the Centers for Disease Control and Prevention also noted that sales of prescription opioids in the United States nearly quadrupled between 1999 and 2014, but there has not been an overall change in the amount of pain Americans report. The legislature further finds that the connection between increased prescriptions for opiates, and similar increases in overdose deaths and substance abuse problems from those prescriptions must be addressed.
Accordingly, the purpose of this Act is to make use of data available within the electronic prescription accountability system to inform practitioners of their opioid prescription rates in relation to their peers by grouping similarly situated practitioners and assigning them a percentile rank within the group according to total opiate prescriptions prescribed for the past year. Under this Act, practitioners will be notified of their percentile ranking solely for the purpose of increasing awareness of their prescription habits; percentile ranking information produced under this Act will be inadmissible in all civil or criminal proceedings and cannot be used as the sole purpose for investigation by a licensure board.
SECTION 2. Section 329-103, Hawaii Revised Statutes, is amended to read as follows:
"[[]§329-103[]]
Designated state agency. The
designated state agency shall:
(1) Oversee and administer the collection of information under the system;
(2) Control access to
the information in the system; [and]
(3) Produce exception
reports as defined in section 329-1[.];
(4) Annually
determine, through the electronic prescription accountability system
established in section 329-101, the mean and median quantity and volume of
prescriptions for opiates listed in section 329-16 as schedule II controlled
substances and listed in section 329-18 as schedule III controlled substances
issued by practitioners registered to utilize the electronic prescription
accountability system under section 329-101; provided that the mean and median
prescription quantities and volumes shall be determined within categories of
practitioners of a similar specialty or practice type as determined by the department;
(5) Work in
conjunction with the respective boards of licensure to annually determine each practitioner's
schedule II and schedule III opiate prescribing quantity and volume, and the
practitioner's standing with regard to the mean and median quantity and volume
for the practitioner's category of specialty or practice type; provided that
the practitioner's standing shall be expressed as a percentile ranking for the
practitioner within the practitioner's category. Each practitioner whose prescribing exceeds
the mean or median within the practitioner's category shall be sent notice of
the practitioner's percentile ranking in a manner determined by the department.
Any practitioner may request the
practitioner's own percentile ranking within the practitioner's own category of
practice. The ranking determined for
each practitioner shall be confidential, shall be distributed by the department
or by the relevant board of licensure only to the practitioner to which the
information pertains, and shall not be admissible as evidence in a civil or
criminal proceeding or be the sole basis for investigation by a licensure
board; and
(6) Coordinate with
the respective boards of licensure to make resources available to practitioners
regarding ways to change prescribing practices and incorporate alternative pain
management options into a practitioner's practice."
SECTION 3. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 4. This Act shall take effect on July 1, 2021.
Report Title:
Electronic Prescription Accountability System; Opiates; Prescription Practices
Description:
Enhances the electronic prescription accountability system to inform practitioners of the percentile ranking of their opiate prescription practices as compared to their peers. Takes effect on 7/1/2021. (SD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.